DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Methadone Hydrochloride is a drug marketed by Hikma, Specgx Llc, Vistapharm, Akorn, Mylan Institutional, Mallinckrodt Inc, Ascent Pharms Inc, Aurolife Pharma Llc, Epic Pharma Llc, Nostrum Labs Inc, Roxane, Sun Pharm Industries, and Thepharmanetwork Llc. and is included in twenty-six NDAs.
The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
A generic version of METHADONE HYDROCHLORIDE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.
Summary for METHADONE HYDROCHLORIDE
Recent Clinical Trials for METHADONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Hennepin Healthcare Research Institute||Phase 2/Phase 3|
|The Emmes Company, LLC||Phase 2/Phase 3|
|University of Alabama at Birmingham||Phase 2/Phase 3|